Fulvestrant is an injectable drug that keeps estrogen from being in contact with malignancy cells. The medication is for postmenopausal ladies who have HER2 proteins on their cancer cells and have attempted estrogen treatment.
Fulvestrant binds to estrogen receptors, creating a nuclear complex, prompting the down-regulation of estrogen receptor protein levels and stopping tumor development.